Latest filing published 25 Feb 2026 for Swedish Orphan Biovitrum AB (publ), €92k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Filippa Stenberg: trading record in brief
Filippa Stenberg is a declared insider of Swedish Orphan Biovitrum AB (publ), with filings sourced from Finansinspektionen. We count 3 filings; the first trade dates from 11 September 2023 and the latest from 25 February 2026.
Both buying and selling appear: 1 purchase worth €92k, against 1 sale worth €3. The net balance comes to €92k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 1 purchase and no sales on the market.
The latest filing, published on 25 February 2026, reports an open-market purchase of €92k in Swedish Orphan Biovitrum AB (publ). Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Filippa Stenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,400 shares@ SEK 407.6809100.0% of flowAktieISIN SE0000872095FI:csv-731d635a8a3f7528f56aCanonical exit: 26 May 2026 (T+90)
- 71 shares@ SEK 142.0099.7% of flowBTA (betald tecknad aktie)ISIN SE0020846293FI:csv-490e06fe818c1bc39e9c
- 3 shares@ SEK 11.19330.3% of flowTeckningsrätt/UniträttISIN SE0020846285FI:csv-f1f4bb18929ef306ef7b
3 of 3 declarations